StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.
| -0.4 | |
| -0.3 | |
| - | |
| -0.37 | |
| -0.46 | |
| 0.04-0.06 | |
| 4 942 K | |
| 124 M | |
| 2 994 K | |
| -0.0072 | |
| 0.074 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - On national TV Sat. May 8 & Sun. May 9, 2021 - BTV-Business Television explores life science investment opportunities including psychedeli...
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - On national TV Sat. May 8 & Sun. May 9, 2021 - BTV-Business Television explores life science investment opportunities including psychedeli...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
